In addition to being a therapeutic target [35], raised IL-6 levels predict development of an oxygen requirement [27, 28] and, along with an elevated NLR, form part of the COVID-19-associated hyperinflammatory syndrome (cHIS) diagnostic criteria [36]. The gene discussed is IL6; the disease is COVID-19.